Infectious Disease Consult
-
Infectious Disease Consult
The challenges of managing CMV infection during pregnancy
Cytomegalovirus infection manifestations in the mother and fetus depend upon the mother’s immune status, the time in gestation that maternal...
-
Infectious Disease Consult
RSV vaccination during pregnancy: Finally ready for prime time
FDA approved in August of this year, the new bivalent RSV prefusion F vaccine represents a major and welcomed breakthrough, as an...
Clinical Review
-
Clinical Review
Case Q: How soon after taking emergency contraception can a patient begin hormonal contraception?
These two, publicly available, guidelines—the US Medical Eligibility for Contraceptive Use and US Selected Practice Recommendations for...
-
Clinical Review
2023 Update on cervical disease
The World Health Organization’s “90-70-90” global strategy targets for vaccination, screening, and treatment to reduce the incidence of cervical...
-
Clinical Review
2023 USPSTF mammography age to start screening in average-risk patients: What’s new is old again
Expert Commentary
-
Expert Commentary
Is the 9-valent HPV vaccine safe and effective long term?
Yes. The 9-valent HPV vaccine conferred immunity for more than 10 years in 80% to 95% of boys and girls who received 3 doses of vaccine...
-
Expert Commentary
Does taking an NSAID while on hormonal contraception increase VTE risk?
It could (although the absolute risk is modest), depending on the risk category of the hormonal contraception and the particular NSAID...
News for Your Practice
-
News for Your Practice
News & Perspectives from Ob.Gyn. News
CONFERENCE COVERAGE
MS, DMTs, and pregnancy: Beware of over-caution regarding treatment
Product Review
-
Product Review
Product Update
From the Editor
-
From the Editor
Breakthroughs in the prevention of RSV disease among infants
RSV disease is a major public health problem among infants younger than age 8 months, causing 100 to 300 deaths annually. In 2023, two new...